Perioperative blood transfusion linked to worse outcomes in renal cell carcinomaNovember 5, 2017Renal Cell CarcinomaGenitourinary Cancer
High EZH2 expression a marker for death risk in RCCOctober 17, 2017Renal Cell CarcinomaGenitourinary Cancer
RANGE: Small PFS edge in urothelial cancer with VEGFR-2 inhibitorSeptember 21, 2017Genitourinary Cancer
PROTECT trial: No DFS benefit with adjuvant pazopanib for high-risk RCCSeptember 14, 2017Renal Cell CarcinomaGenitourinary Cancer
Is pain or dependency driving elevated opioid use among long-term cancer survivors?September 6, 2017GastroenterologyPatient & Survivor CareLung CancerGenitourinary CancerGynecologic CancerGastrointestinal Cancer
FDA advisory committee to consider adjuvant sunitinib for RCCAugust 16, 2017Renal Cell CarcinomaGenitourinary Cancer
Sequential pazopanib and everolimus nets good survival in metastatic RCCAugust 8, 2017Renal Cell CarcinomaGenitourinary Cancer
No survival benefit with adjuvant girentuximab in high-risk RCCJuly 19, 2017Renal Cell CarcinomaGenitourinary Cancer
Savolitinib improves PFS in some with MET-driven papillary renal cell carcinomaJuly 6, 2017Renal Cell CarcinomaGenitourinary Cancer
PROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCCJune 19, 2017Renal Cell CarcinomaGenitourinary Cancer
Hypogonadism after testicular cancer treatment can have lifelong impactJune 14, 2017Genitourinary CancerPatient & Survivor Care
